279 related articles for article (PubMed ID: 27472388)
1. Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells.
Nomura A; Dauer P; Gupta V; McGinn O; Arora N; Majumdar K; Uhlrich C; Dalluge J; Dudeja V; Saluja A; Banerjee S
Oncotarget; 2016 Aug; 7(35):56324-56337. PubMed ID: 27472388
[TBL] [Abstract][Full Text] [Related]
2. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity.
Gupta VK; Sharma NS; Kesh K; Dauer P; Nomura A; Giri B; Dudeja V; Banerjee S; Bhattacharya S; Saluja A; Banerjee S
Cancer Lett; 2018 Dec; 439():101-112. PubMed ID: 30290209
[TBL] [Abstract][Full Text] [Related]
3. Labeling Cancer Stem Cells with
Kesh K; Banerjee S
Methods Mol Biol; 2019; 1996():207-216. PubMed ID: 31127559
[TBL] [Abstract][Full Text] [Related]
4. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
[TBL] [Abstract][Full Text] [Related]
6. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.
Maeda K; Ding Q; Yoshimitsu M; Kuwahata T; Miyazaki Y; Tsukasa K; Hayashi T; Shinchi H; Natsugoe S; Takao S
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367674
[TBL] [Abstract][Full Text] [Related]
7. CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.
Banerjee S; Nomura A; Sangwan V; Chugh R; Dudeja V; Vickers SM; Saluja A
Clin Cancer Res; 2014 May; 20(9):2388-99. PubMed ID: 24634377
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
[TBL] [Abstract][Full Text] [Related]
9. MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133
Yang L; Li N; Yan Z; Li C; Zhao Z
J Mol Neurosci; 2018 Nov; 66(3):369-377. PubMed ID: 30267383
[TBL] [Abstract][Full Text] [Related]
10. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.
Kim D; Park M; Jang H; Hyun H; Lim W
Lasers Med Sci; 2018 Jan; 33(1):57-66. PubMed ID: 28956217
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Tumor Progression Associated With CD133 Overexpression: Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation.
Weng CC; Kuo KK; Su HT; Hsiao PJ; Chen YW; Wu DC; Hung WC; Cheng KH
Pancreas; 2016 Mar; 45(3):443-57. PubMed ID: 26646272
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
Mei D; Lv B; Chen B; Xiao S; Jiang J; Xie Y; Jiang L
PLoS One; 2017; 12(8):e0182835. PubMed ID: 28817605
[TBL] [Abstract][Full Text] [Related]
13. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
15. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment.
Song YJ; Zhang SS; Guo XL; Sun K; Han ZP; Li R; Zhao QD; Deng WJ; Xie XQ; Zhang JW; Wu MC; Wei LX
Cancer Lett; 2013 Oct; 339(1):70-81. PubMed ID: 23879969
[TBL] [Abstract][Full Text] [Related]
16. Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness.
Zhang L; Shi H; Chen H; Gong A; Liu Y; Song L; Xu X; You T; Fan X; Wang D; Cheng F; Zhu H
Cell Death Dis; 2019 Sep; 10(10):724. PubMed ID: 31558702
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling Warburg effect and stemness in CD133
Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
[TBL] [Abstract][Full Text] [Related]
18. NFκB-Mediated Invasiveness in CD133
Nomura A; Gupta VK; Dauer P; Sharma NS; Dudeja V; Merchant N; Saluja AK; Banerjee S
Mol Cancer Res; 2018 Jan; 16(1):162-172. PubMed ID: 28970361
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.
Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y
Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785
[TBL] [Abstract][Full Text] [Related]
20. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
